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Abstract
Background: HAND2, a key regulator for the development of the sympathetic nervous system, is
located on chromosome 4q33 in a head-to-head orientation with DEIN, a recently identified novel
gene with stage specific expression in primary neuroblastoma (NB). Both genes are expressed in
primary NB as well as most NB cell lines and are separated by a genomic sequence of 228 bp. The
similar expression profile of both genes suggests a common transcriptional regulation mediated by
a bidirectional promoter.
Results: Northern Blot analysis of DEIN and HAND2 in 20 primary NBs indicated concurrent
expression levels of the two genes, which was confirmed by microarray analysis of 236 primary NBs
(Pearson's correlation coefficient r = 0.65). While DEIN expression in the latter cohort was
associated with stage 4S (p = 0.02), HAND2 expression was not associated with tumor stage. In
contrast, both HAND2 and DEIN transcript levels were highly associated with age at diagnosis <12
months (p = 0.001). The intergenic region shows substantial homology in different species (89%,
72% and 53% identity between human and mouse, chicken and zebrafish, respectively) and contains
many highly conserved putative transcription factor binding sites. Using luciferase reporter gene
constructs, asymmetrical bidirectional promoter activity was found in four NB cell lines: In DEIN
orientation, an average 3.4 fold increase in activity was observed as compared to the promoterless
vector, whereas an average 15.4 fold activation was detected in HAND2 orientation. The presence
of two highly conserved putative regulatory elements, one of which was shown to enhance HAND2
expression in branchial arches previously, displayed weak repressor activity for both genes.
Conclusion: HAND2 and DEIN represent a gene pair that is tightly linked by a bidirectional
promoter in an evolutionary highly conserved manner. Expression of both genes in NB is co-
regulated by asymmetrical activity of this promoter and modulated by the activity of two cis-
regulatory elements acting as weak repressors. The concurrent quantitative and tissue specific
expression of HAND2 and DEIN suggests a functional link between both genes.
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Background
HAND2  is a basic helix-loop-helix transcription factor
that is expressed in the developing heart, neural crest deri-
vates and autonomic nervous system including sympa-
thetic neurons, adrenal chromaffin cells and enteric
neurons [1]. HAND2 plays a key role in the development
and differentiation of the sympathetic nervous system by
promoting differentiation of neural crest derived precur-
sors into catecholaminergic neurons and maintaining the
neural precursor pool of cells [2,3]. Functional analyses
showed that HAND2  belongs to the group of BMP
induced transcription factors that acts downstream of
PHOX2B and upstream of GATA2, GATA3, PHOX2A and
the noradrenergic marker genes Tyrosine Hydroxylase (TH)
and Dopamine Beta Hydroxylase (DBH) [3,4]. In addition,
HAND2  is highly expressed in neuroblastoma (NB), a
pediatric tumor arising from undifferentiated migrating
sympathetic precursor cells that shows conspicuously
divergent biological phenotypes ranging from spontane-
ous regression to rapid progression and metastasis [5].
Recently, we have reported on the identification of DEIN,
a novel gene with high expression in NB of children <1
year of age and stage 4S NB, both of which are associated
with a good prognosis and spontaneous regression [6].
Given the lack of a putative coding region, DEIN was pre-
dicted to represent a noncoding RNA whose function in
NB and sympathetic nervous system development is yet
unclear. DEIN is located on chromosome 4q33–34 in a
head-to-head orientation with HAND2 with both genes
being separated by a nucleotide sequence of 228 bp. The
close vicinity and divergent configuration of both genes
together with their concurrent tissue specific expression
pattern suggests a common transcriptional regulation that
is mediated by the intergenic sequence. Bidirectional gene
organisation was shown to represent a common feature in
the human genome with approximately 10% of all genes
showing this configuration. Many of these gene pairs were
shown to be co-regulated and/or functionally related [7].
This study aimed to examine the potential of the inter-
genic region to direct transcription in HAND2 and DEIN
orientation, thereby acting as a bidirectional promoter. In
addition, conservation and structural features such as
putative transcription factor binding sites (TFBS) of the
genomic region were analyzed. To test whether the expres-
sion of both genes is co-regulated in NB in vivo and asso-
ciated with prognostic factors, expression levels of DEIN
and HAND2 were examined in a cohort of 236 primary
NBs of different stages by microarray analysis.
Results
Determination of transcriptional start sites and the 
nucleotide structures of HAND2 and DEIN transcripts in NB
The human HAND2  gene was initially cloned from a
human fetal cardiac cDNA library by Russel et al. [8]. The
1.3 kb long consensus sequence derived from cDNA
clones AF087940 and AF087941 was shorter than the 2.3
kb transcript detected in Northern Blot, and the authors
expected the unaccounted sequence to be located in the
3'-UTR of the gene. However, numerous transcribed
sequences containing the coding region of HAND2 and
extending several 100 bp in 5'-direction have been sub-
mitted to GenBank in recent years suggesting that the
unaccounted sequence is most probably located upstream
of the coding region. In order to determine the transcrip-
tional start site and the full length sequence of the main
HAND2  transcript in NB, we performed a combined
RACE- and RT-PCR approach. The resulting transcript is
2351 bp long and comprises two exons of 1495 and 856
bp (GenBank accession FJ226608). The 5'-sequence of the
first exon extends into a CpG island with an average GC-
content of 70% which might have impeded the full-length
cloning of the human transcript in previous attempts. Our
results are well in line with the reported length of 2.3 kb
by Northern Blot hybridization from heart tissue [8] and
our Northern Blot analyses. The genomic structure of
HAND2 with a long first and a shorter second exon with
the coding region being interrupted by an intron is highly
conserved in other species such as mouse, rat, chicken and
zebrafish (data not shown). Furthermore, the transcrip-
tional start site of HAND2 is highly conserved in all of
these species. The 5'-end of FJ226608 is identical with the
start sites of mRNA AK122739 and EST DA609347, both
of which were derived from NB cell line IMR-32. In con-
trast, the HAND2 reference sequence NM_021973, which
has not been experimentally confirmed, lacks two nucle-
otides at its 5'-end as compared to our transcript. The
cloning procedures and the nucleotide structures of the
DEIN transcript variants have been described in detail pre-
viously [6].
Quantitative expression of HAND2 and DEIN in primary 
NB
To determine whether expression of HAND2 and DEIN is
co-regulated in neuroblastoma, we performed Northern
Blot analysis of 20 primary NB with HAND2- and DEIN-
specific cDNA probes. We detected strong expression of
both genes in all stage 4S tumors, moderate to low expres-
sion in localized tumors, and little or no expression in
stage 4 tumors (fig. 1). In NB cell lines, expression of
DEIN and HAND2 was detected in cell lines SH-SY5Y and
Kelly, but it was absent in cell line SH-EP. The concurrent
transcript levels of HAND2 and DEIN in primary NB and
NB cell lines indicated a co-regulated expression of both
genes in NB.
To validate these results, expression of DEIN and HAND2
was analyzed in a set of 236 primary NB samples by
microarray analysis (see Additional file 1). Patients diag-
nosed before the age of one year had significantly higher
DEIN  and  HAND2  expression values as compared toBMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
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patients diagnosed later (both p = 0.001; fig. 2A and 2B).
Expression of both genes was also significantly higher in
children diagnosed before the age of 18 months as com-
pared to older patients (both p = 0.01; data not shown).
As expected, DEIN expression was significantly higher in
tumors of stage 4S than in those of stage 4 (p = 0.02).
These results are in line with our previous study that
reported on a strong association between DEIN expres-
sion and stage 4S as well as age < 1 year in a cohort of 121
primary NBs by real-time RT-PCR [6]. However, in con-
trast to the results of our previous study [6], DEIN expres-
sion was neither significantly different between stage 4
and localized stages, nor between stage 4S and localized
stages in the micoarray analyses (data not shown). This
discrepancy might be explained by the high percentage of
patients <12 months of age among localized tumors in the
microarray cohort (81/119 patients, 68%). HAND2
mRNA levels were not associated with either stage, which
is in agreement with a study of Gestbloom et al., who
reported that HAND2  is expressed independently of
tumor stage or differentiation in NB [5]. Nevertheless,
HAND2 and DEIN expression values were well correlated
in our study (Pearson's correlation coefficient r = 0.65, fig.
2C). Together, these findings support the hypothesis that
expression of HAND2 and DEIN is co-regulated in pri-
mary NB.
Characterization of the putative bidirectional promoter 
sequence between HAND2 and DEIN
The putative promoter between HAND2  and  DEIN  is
located within a CpG island (GC-content of 70%) that
extends into the first exon of HAND2 (fig. 3). The inter-
Northern Blot analysis of HAND2 and DEIN expression in primary NB and NB cell lines Figure 1
Northern Blot analysis of HAND2 and DEIN expression in primary NB and NB cell lines. Ten μg of total RNA from 
20 primary NBs (stage 1, n = 3; stage 2, n = 3; stage 3, n = 3; stage 4S, n = 5; stage 4, n = 6) and NB cell lines SH-EP, SH-SY5Y 
and Kelly were blotted and hybridized with HAND2- and DEIN-specific cDNA-probes; β-actin was used as loading control.
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DEIN and HAND2 expression in 236 primary neuroblastomas as determined by microarray analysis Figure 2
DEIN and HAND2 expression in 236 primary neuroblastomas as determined by microarray analysis. Relative 
expression levels of DEIN (A) and HAND2 (B) in neuroblastoma subsets according to age at diagnosis. Scatter Plot showing 
correlation of relative expression values for HAND2 and DEIN (C); r, Pearson's correlation coefficient.
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genic region shows high evolutionary conservation with
89, 71 and 53% nucleotide identity of the human
sequence in comparison to mouse, chicken and zebrafish,
respectively. The high degree of homology is comparable
to that of the coding region of HAND2 which shows 92,
88 and 68% identity of the human sequence in compari-
son to mouse, chicken and zebrafish, respectively.
No TATA-Box, but various other highly conserved poten-
tial transcription regulatory elements were found in the
bidirectional promoter (fig. 4). These include two GC-
boxes with SP-1 sites and one AP-1 site in DEIN-orienta-
tion as well as one AP-2 site in HAND2-orientation. Four
binding sites for zinc finger transcription factors GATA-1
or -2 (two each in DEIN and HAND2 orientation, respec-
tively) were detected. We also found four binding sites for
homeobox transcription factors including three binding
sites for CdxA (one in HAND2 orientation and two in
DEIN orientation), and one binding site each for Abd-B
and Prx2 in HAND2 orientation. Finally, a highly con-
served site for cAMP response element-binding protein
(CREB) in both orientations and a highly conserved cen-
trally located CCAAT box in HAND2  orientation were
detected. Evolutionary conservation was found for the
CDxA, CREB and the CCAAT binding sites in all vertebrate
species investigated, while SP1, AP1 and 2, Abd-B and
GATA binding sites were only conserved in mouse and/or
chicken.
Asymmetrical activity of the bidirectional promoter 
between DEIN and HAND2
To test the ability of the putative bidirectional promoter to
activate transcription in DEIN and HAND2 orientation, it
was cloned separately or together with two other highly
conserved putative regulatory elements in both orienta-
tions into a luciferase reporter vector. A total of six reporter
gene constructs were transfected into four neuroblastoma
cell lines (summarized in fig. 3). It was demonstrated that
the bidirectional promoter is able to drive expression in
both HAND2 and DEIN direction in all cell lines with ~4
fold higher activity in HAND2 orientation than in DEIN
orientation. In DEIN orientation the promoter caused a
2.2 – 5 fold activation (mean value, 3.4) as compared to
the promoterless vector (p < 0.01 for all cell lines except
SH-SY5Y, which is probably due to the lower transfection
efficiency of SH-SY5Y). A 4.9 – 25.5 fold increase in activ-
ity (mean value, 15.4) was detected for the promoter in
HAND2 orientation in all cell lines as compared to the
promoterless vector (p < 0.01 for all cell lines).
To test whether promoter activity is influenced by either of
two other highly conserved sequence fragments that are
located within the genomic sequence covered by DEIN,
we cloned these elements either upstream or downstream
of the luciferase gene in the respective orientations relative
to the bidirectional promoter according to their actual
genomic position (constructs B, C, E and F, fig. 3A). The
presence of a 90 bp long regulatory element that was
shown to act as enhancer for HAND2  expression in
branchial arches [9] decreased luciferase activity in both
DEIN and HAND2 orientations. For construct C, an aver-
age 2.6 fold reduction in activity was detected as com-
pared to construct A (p = 0.05 for SK-N-AS, SH-EP and
Kelly; not significant [n.s.] for SH-SY5Y). For construct F,
an average 4.4 fold reduction in activity was detected as
compared to construct D (p = 0.05 for Kelly; n.s. for SH-
SY5Y, SH-EP and SK-N-AS).
Another highly conserved sequence element of 302 bp
located in exon 5 of DEIN, which has been suggested to
represent a cis-regulatory element for DEIN  and/or
HAND2 expression [6], also exerted weak repressor activ-
ity on both promoters. For construct B, we detected an
average 1.1 fold reduction in activity as compared to con-
struct A (p < 0.05 for SH-EP, SK-N-AS and Kelly; n.s. for
SH-SY5Y). For construct E, we detected an average 3.2 fold
reduction as compared to construct D (p < 0.05 for SH-EP;
n.s. for SH-SY5Y, SK-N-AS and Kelly).
Discussion
In this study, we report on the molecular characterization
of a highly conserved intergenic nucleotide sequence
between HAND2 and DEIN which functions as a bidirec-
tional promoter. Bidirectional gene configuration,
defined as two divergently transcribed genes that are sep-
arated by less than 1 kb, is a common architectural feature
in the human genome and was shown to account for co-
regulated and/or tissue specific expression of functionally
related genes [10]. Most of these genes have been reported
to belong to the group of housekeeping genes many of
which are involved in DNA repair and replication [7]. In
recent years, other non-homologous bidirectional gene
pairs were identified with functions in senescence [11],
antigen presentation [12], brain disease [13,14], oncogen-
esis or tumor supression [15-17].
Structure and conservation of the bidirectional promoter
The majority of bidirectional promoters are less than 300
bp in length, have a median GC-content of 66% and asso-
ciate with CpG-islands in 75% [7]. All these features are
present in the common promoter region of HAND2 and
DEIN, which is 228 bp long, contains 13 CpG sites and has
a GC-Content of 70%. Interestingly, the distance between
HAND2 and DEIN remained stable throughout evolution
with only 14 and 7 additional nucleotides in the human
sequence as compared to chicken and mouse, respectively.
Although there is no systematic evaluation on the altera-
tion of the genomic distance between bidirectional gene
pairs throughout evolution, we found examples reporting a
far more dramatic increase of several hundreds of bp [11].BMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
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Genomic organization of the human HAND2-DEIN locus on 4q33–34 and luciferase reporter-gene constructs A-H (A); Relative  luciferase activity of constructs A-H in NB cell lines SK-N-AS, SH-EP, SH-SY5Y and Kelly (B) Figure 3
Genomic organization of the human HAND2-DEIN locus on 4q33–34 and luciferase reporter-gene constructs 
A-H (A); Relative luciferase activity of constructs A-H in NB cell lines SK-N-AS, SH-EP, SH-SY5Y and Kelly 
(B). Boxes and lines indicate exons and introns, respectively. Arrows indicate direction of transcription. Blue bars, DEIN orien-
tation; green bars, HAND2 orientation; BP, Bidirectional Promoter; luc, luciferase; BAE, HAND2 Branchial Arch Enhancer; C, 
putative cis-regulatory element; SVE/SVP, SV40 enhancer- and promoter-elements, respectively. Values of transfection experi-
ments are shown as the mean ± standard deviation of 3 independent experiments. Values are normalized to the activity of the 
pGL3-Basic vector set as 1.
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The constancy of the intergenic distance between HAND2
and DEIN might thus be indicative of the selective pressure
that was acting to maintain the close distance of the genes
over a long evolutionary period.
The nucleotide sequence, exon number and transcript
structure including intron-exon boundaries of HAND2 are
highly conserved among different species including
chicken and zebrafish. In contrast, DEIN is only conserved
in mouse and chicken but not zebrafish, and shows an
overall lower conservation that decreases in 3'-direction
with the highest conservation in exons 1 and 2 and a region
in exon 5 [6]. Numerous transcribed sequences matching
nearly all exons of DEIN were found in mouse and chicken,
but not in zebrafish. Tissue sources for these sequences
included typical HAND2 expressing tissues such as heart,
and embryonic or fetal tissues such as trophoblast and
developing sympathetic ganglia, respectively [6]. We con-
clude from these findings that (1) DEIN has probably first
evolved after zebrafish in higher vertebrates, and that (2)
bidirectional transcription of HAND2 and DEIN is proba-
bly evolutionary conserved in higher vertebrates such as
rodents and birds. The latter conclusion is further sup-
ported by large-scale comparative analyses of bidirectional
promoters in vertebrates using orthology assignments,
according to which many bidirectional promoters have
emerged after the divergence of birds and fish [18].
Asymmetrical activity of the bidirectional promoter in NB 
cell lines
The activity of the bidirectional promoter in four NB cell
lines was shown to be asymmetric with strong activity in
HAND2  and moderate activity in DEIN  orientation.
Asymmetric activity has been reported previously for
other divergently transcribed gene pairs [13,19].
The comparatively low activity of the promoter in DEIN
orientation is surprising regarding the strong expression
of DEIN in primary NB as indicated by SAGE, Northern
Blot and RT-PCR analysis (fig. 1 and [6]). DEIN expres-
sion might possibly require additional cis-regulatory ele-
ments that were not included in our constructs.
Alternatively, activation of the promoter in DEIN orienta-
tion could also depend on transcriptional activators
absent in NB cell lines, which are derived from rapidly
progressing tumors characterized by rather low DEIN
mRNA levels [6]. Transcript levels of both genes might
also be further modified by post-transcriptional mecha-
nisms such as mRNA modification or degradation.
Two other highly conserved sequence elements, one of
which was shown to function as an enhancer for HAND2
transcription in branchial arches [9], appear to act as weak
repressors for both DEIN and HAND2 transcription in
NB. However, the in vitro repressive activity could also be
Sequence alignment of the complete nucleotide sequence of the bidirectional promoter between HAND2 and DEIN in human  (hs), chimpanzee (pt), mouse (mm), rat (rn), chicken (gg) and zebrafish (dr) Figure 4
Sequence alignment of the complete nucleotide sequence of the bidirectional promoter between HAND2 and 
DEIN in human (hs), chimpanzee (pt), mouse (mm), rat (rn), chicken (gg) and zebrafish (dr). First exons of 
HAND2 and DEIN are shaded in grey. Direction of transcription is indicated by black arrows. Nucleotides are numbered rela-
tive to the first nucleotide of the bidirectional promoter. Putative Trancription Factor Binding Sites (TFBS) are boxed. The 
directionality of TFBS is indicated by arrowheads and color of boxes (<, blue, HAND2-orientation; >, red, DEIN-orientation). 
SP-1, specificity protein 1; AP-1 and AP-2, activator protein 1 and 2; CdxA, CdxA homeobox gene; Abd-B, Abdominal-B; 
CREB, cAMP response element-binding protein; Prx2, paired related homeobox 2.
൸HAND2 CdxA> CdxA>  <CREB> <GATA1/2   <AP2  GCBox/SP1>
hs.chr4  ccatgtacagctacatctttagggccgctcgggttaatatatgtcgtcagaggctcctcacgccaatcccggggcggcaggggcggcgcct  79 
pt.chr3  ccatgtacagctacatctttagggccgctcgggttaatatatgtcgtcagaggctcctcacgccaatcccggggcggcaggggcggcgcct  79 
mm.chr8  ccatgtacagctacatctttagggccgctcgggttaatatatgtcgtcagaggctcctcacgccaatcccggggcggcgggggcggcgcct  79 
rn.chr16 ccatgtacagctacatctttagggccgctcgggttaatatatgtcgtcagaggctcctcacgccaatccctgccggcgggggcggagtcct  79 
gg.chr4  ccatggacagctacatgtttagggccgctcgggttaatatatggcgtcagaggcggccaccgccaatggctgccggc-gggggcggagtcc  78 
dr.chr1  ccatgt-cagctacatcttttgagctgcttgggttcatatatgtcgtcaaaactcttctcagccaataacgttgcagaggaggaggtacat  79
<Abd-B <Prx2 GATA1/2> <CCAAT
hs.chr4  cgagctctcggcaataaaactttttgatgttcacgttgct-aattgc-cgaggtcct-----cttccag—-gattggctacctcctcataa 161 
pt.chr3  cgagctctcggcaataaaactttttgatgttcacgttgct-aattgc-cgaggtcct-----cttccag—-gattggctacctcctcataa 161 
mm.chr8  cgcgctctccgcaataaaactttttgatgttcacgttgct-aattgc-cgaggtcct-----cttctag—-gattggttgtccactcataa 161 
rn.chr16 cgcgctctccgcaataaaactttttgatgttcacgttgct-aattgc-cgaggtcct-----cttctag—-gattggttgtccactcataa 161 
gg.chr4  -cggggctccgcaataaaactttttgatgtcggccccgct-aattgc-cgcgctcct-----cggccgg—-gattggctgcccctccgcat 160 
dr.chr1  ----------gaactacatcgttagggtgtttacgcttccaaattgctcgaactcttaaaagcagccaacttattggttacatagacaaaa 160
GATA1/2> <CdxA GCBox/SP1> <GATA1/2 AP1> DEINൺ
hs.chr4  c-cataagataattaaaacttggcggggggggggggcagggttaaaaaaacttt-ttttat-cagtcagaggataatgcaagtgtttaaca 249 
pt.chr3  c-cataagataattaaaacttggcgggggga-ggggcagggttaaaaaaacttttttttat-cagtcagaggataatgcaagtgtttaaca 249 
mm.chr8  c-cataagataattaaaac—------ggggg-ggggcagggtaaaaaaaaaacccttttat-cagccataggttaatgcaagtgtttaaca 242 
rn.chr16 c-cataagataattaaaac—------aaggg-ggggcagggttaaaaaaaa---cttttac-cagccataggttaatgcaagtgtttaaca 239 
gg.chr4  c-cagagcgtaattaaaac—------gaggggggg-gggggggggaa-------ttgtcatggaggcagaggttaatgcaagtgtttagca 235 
dr.chr1  tgtattaaataaatatcactt------a------------tttaaaaaaaa-------------------gg-taat-------------- 199BMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
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a result of steric inhibition of transcription factors, since
the genetic distance between the two regulatory elements
and the promoter in the genome is about 6 – 8 kb,
whereas it is only 44 bp – 1.9 kb in the luciferase reporter
constructs.
Transcriptional regulation and putative functional link of 
HAND2 and DEIN in NB
Tissue specific regulation of HAND2 expression by cis-reg-
ulatory elements located in its upstream genomic region
has been extensively studied in heart and branchial
arches, but to date, genomic elements that are critical for
HAND2 expression in the developing sympathetic nerv-
ous system have not been identified. In heart, HAND2
transcription depends on an enhancer element consisting
of two conserved GATA  sites that are dispersed over a
genomic region of 1.5 kb between exon 3 and 4 of DEIN
with an overall low conservation [20]. In branchial arches,
HAND2 expression depends on endothelin-signaling via
Dlx6  which binds to a highly conserved 200 bp long
enhancer element located between exon 3 and 4 of DEIN
[9]. According to McFadden et al. who studied regulatory
elements for HAND2 expression in mouse, the genomic
region 11 kb upstream of hand2 did not direct expression
in sympathetic ganglia [20]. This result seems to be in
contrast with our finding of a strong transcriptional acti-
vation of a reporter gene by the 228 bp upstream region
of HAND2 in human NB cells that are suggested to derive
from sympathicoadrenal precursors.
Our data indicate that the bidirectional promoter is an
important element for HAND2 expression in sympathi-
coadrenal tissues, although the exact transcriptional acti-
vators have not been specified yet. It has been
demonstrated earlier that Phox2b  knockout mice lack
Hand2 expression [21]. These data strongly suggest that
PHOX2B, a master gene required for the development and
differentiation of autonomic neurons [22], is an upstream
activator of HAND2 in the developing sympathetic nerv-
ous system [2,3,23]. Expression analyses of PHOX2B,
HAND2 and DEIN in NB cells lines SH-SY5Y and SH-EP,
two well-studied subclones of SK-N-SH with a neuronal-
like and epithelial-like phenotype, respectively [24], fur-
ther suggest that not only HAND2, but also DEIN is a tar-
get gene of PHOX2B: In cell line SH-EP, PHOX2B
expression was shown to be absent [25], and likewise, nei-
ther  HAND2  nor  DEIN  was expressed in SH-EP cells
according to our Northern Blot analysis (fig. 1); in con-
trast, all three genes are expressed in cell line SH-SY5Y
([25] and fig. 1). In order to investigate whether DEIN and
HAND2 are possible downstream targets of PHOX2B in
primary NB, we simultaneously examined DEIN  and
HAND2 mRNA levels in sixty selected tumors with high
and low PHOX2B  expression values using microarrays
(fig. 5). Tumors of both subgroups showed largely con-
cordant expression levels of DEIN and HAND2. However,
whereas low expression levels of PHOX2B were consist-
ently associated with low mRNA levels of DEIN  and
HAND2 in the vast majority of cases, the degree of corre-
lation appeared to be lower for tumors with high PHOX2B
expression levels. These observations provide further evi-
dence that PHOX2B may act as an upstream activator of
both DEIN and HAND2, although additional factors may
be necessary to induce expression of these genes in NB.
Taking the presence of multiple conserved binding sites
for homeobox transcription factors within the bidirec-
tional promoter and the concurrent expression of HAND2
and DEIN in NB into account, it is tempting to speculate
that PHOX2B could actually represent a direct transcrip-
tional activator for HAND2 and DEIN via the common
promoter sequence.
The known PHOX2B  downstream targets HAND2  and
PHOX2A were shown to promote differentiation of sym-
pathicoadrenal cells and expression of noradrenergic
marker genes. In NB cell lines, forced over-expression of
wild-type PHOX2B was shown to suppress cell prolifera-
tion and promote differentiation [26]. As another hypo-
thetical PHOX2B target gene, DEIN might be involved in
these cellular processes. This is particularly interesting in
the light of the strong DEIN expression in tumors of stage
4S and those of children diagnosed <1 year of age. Since
these tumors are associated with a good prognosis and
often follow spontaneous regression, they have been spec-
ulated to represent embryonal remnants rather than
malignant tumors [27].
Bidirectional gene pairs have been shown to be function-
ally related, e.g. in DNA repair [7], senescence [11] or
brain disease [13,14]. The concurrent quantitative and tis-
sue specific expression of both genes ([6], fig. 1 and 2C)
suggests that HAND2 and DEIN are regulated by common
transcriptional mechanisms in a restricted range of tissues
during early developmental stages. The bidirectional pro-
moter probably plays an important role in coordinating
HAND2 and DEIN expression in a similar spatial and tem-
poral fashion. However, the functional relevance of the
linkage between DEIN  and  HAND2  expression by the
bidirectional promoter requires further investigation, e.g.
functional studies on DEIN and experiments elucidating
the transcription factors that bind to the promoter region.
Conclusion
HAND2 and DEIN represent a gene pair that is tightly
linked by a bidirectional promoter in an evolutionary
highly conserved manner. The activity of the promoter in
NB cell lines is asymmetric with strong activity in HAND2
and moderate activity in DEIN  orientation. Expression
studies strongly suggest co-regulation of both genes, and
their high expression in tissues corresponding to theBMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
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developing sympathetic nervous system suggests a func-
tional link between HAND2 and DEIN. Co-regulated and
tissue specific expression are likely both mediated by the
bidirectional promoter, which appears to be evolutionary
highly conserved in rodents and birds. Concordant
expression levels of HAND2, DEIN and PHOX2B in many
primary NB and NB cell lines suggest that PHOX2B acts as
an upstream transcriptional activator for both genes.
Regarding the key role of HAND2 in the differentiation of
neural crest derived precursors into sympathetic neurons
and the high expression of DEIN  in spontaneously
regressing NB, DEIN could be instrumental in biological
phenomena like regression and differentiation, which are
characteristic for favourable NB and the developing sym-
pathetic nervous system.
Methods
3'- and 5'-RACE-PCR
To identify the 5'-ends of HAND2 and DEIN, 5'-RACE-
PCR was performed using the SMART™RACE cDNA
Amplification Kit (Clontech, Mountain View, USA) with
the gene specific primers GSPH2 for HAND2 and GSPD1
for DEIN. Cloning of the 3'-end of HAND2 was performed
using the SMART™RACE cDNA Amplification Kit (Clon-
tech) with the gene specific primer GSPH1 (table 1).
Synthesis of cDNA, cloning and sequencing of PCR 
products
Generation of cDNA used for 5'- and 3'-RACE-PCR and
RT-PCR was performed with 0.4 – 2 μg of poly(A)-RNA of
a primary stage 4S neuroblastoma. For RT-PCR, cDNA-
synthesis was performed with the QIAGEN LongRange
2Step RTPCR kit according to the manufacturer's protocol.
Cloning of PCR products was carried out using the TOPO
TA®-Vector (Invitrogen). Sequencing was performed using
the BigDye terminator sequencing kit, Version 3.1
(Applied Biosystems).
Reverse transcriptase (RT)-PCR
PCR was carried out in a total volume of 50 μl containing
1  μl first strand cDNA, 2 U HiFi Platinum-Taq DNA
Polymerase (Invitrogen), 125 nM sense and anti-sense
primer each, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 200
nM dNTPs each and 1.5 mM MgSO4 (Invitrogen). Cycling
conditions consisted of a single denaturation step at 95°C
for 3 min, followed by 35 cycles of 95°C for 1 min, 58°C
for 1 min, 72°C for 11.5 min and a final extension step at
72°C for 15 min. For the amplification of overlapping
subfragments of HAND2, the primer combinations F1 +
R4 and F3 + R3 (table 1) were used. PCR products were
visualized on a 2% agarose gel. As a negative control, RT-
PCR reactions were performed containing 1 μl of first
strand cDNA reactions without reverse transcriptase to
exclude amplification of contaminating genomic DNA.
Hierarchical cluster analysis of 60 primary neuroblastomas  with high and low PHOX2B expression levels according to  expression of DEIN, HAND2 and PHOX2B as determined by  microarray analysis Figure 5
Hierarchical cluster analysis of 60 primary neuroblas-
tomas with high and low PHOX2B expression levels 
according to expression of DEIN, HAND2 and 
PHOX2B as determined by microarray analysis. Lines 
represent patients, columns represent genes. Gene expres-
sion levels are visualized as log-values ranging from blue (-
0.5) to red (+0.5).
P
H
O
X
2
B
H
A
N
D
2
D
E
I
NBMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
Page 9 of 11
(page number not for citation purposes)
Northern Blot analysis
Ten μg of total RNA from 20 randomly selected primary
NB specimen (stage 1, n = 3; stage 2, n = 3; stage 3, n = 3;
stage 4S, n = 5; stage 4, n = 6) and 3 NB cell lines (SH-EP,
SH-SY5Y and Kelly) were size-fractioned on a 1% denatur-
ating formaldehyde agarose gel and transferred onto a
nylon membrane (Roche Diagnostics, Mannheim, Ger-
many) using Northern Max One-Hour Transfer Buffer
(Ambion, Cambridgeshire, UK). Specific cDNA-probes
for DEIN, HAND2 and β-actin were generated by RT-PCR.
Primers used for amplification of specific cDNA-probes
were F4 + R5 for DEIN, and F2 + R3 for HAND2 (table 1).
Blots were hybridized overnight at 42°C in UltraHyb
Hybridization Buffer (Ambion) with high sensitivity strip-
pable DNA probes labelled with [α32P]-dATP (Strip-EZ
DNA kit, Ambion). After hybridization, membranes were
washed, air-dried and exposed to Kodak BioMax MR-1
films (Amersham, Freiburg, Germany).
Microarray analysis and statistical analysis of expression data
Gene expression profiles from 236 patients (localized
stages, n = 119; stage 4S, n = 28; stage 4, n = 89; age <1
year, n = 128; age >1 year, n = 108) were generated as dye-
flipped dual-color replicates using customized 11 K
microarrays as described [28]. This set of patients did nei-
ther overlap with the cohort of the Northern Blot analysis
nor with the cohort of our previous study [28]. Variables
of interest (stage and age at diagnosis) and relative DEIN
and HAND2 expression levels were compared using Chi-
square-test, Kruskal-Wallis test or Mann-Whitney-U-test
where appropriate. Correlation of relative expression val-
ues was calculated with Pearson's correlation coefficient.
Hierarchical clustering analyses was performed using the
Rosetta Resolver Software (Version 7.2; Rosetta Inphar-
matics LCC, Seattle). From the whole set of 236 patients,
groups with highest (n = 30) and lowest (n = 30) PHOX2B
expression were picked and used for the clustering. The
analysis was performed using Complete Linkage and
Cosine Correlation as metric variables.
Sequence analysis
The GC-content and CpG islands were determined using
CpGplot http://www.ebi.ac.uk/emboss/cpgplot. Homol-
Table 1: Oligonucleotides used as primers in this study
method name nucleotide sequence
3'-RACE GSPH1 5'-CATGGACCTGCTGGCCAAGGACG-3'
5'-RACE GSPH2 5'-CTGAATGAGCCTTGGAGCTCGAAG-3'
GSPD1 5'-GCCAATCTGCAGTTTGTCTTTCTG-3'
reporter gene constructs BPF 5'-TTTTAAGCTTACATCTTTAGGGCCGCTCG-3'
BPR 5'-TTTTAAGCTTGTTAAACACTTGCATTATCCTCTG-3'
CDF 5'-TTTTGGATCCACCTTTCGCCGGAGGCGA-3'
CDR 5'-TTTTGGATCCAGCGAGCGGCTGCAGATTTG-3'
CHF 5'-TTTTACGCGTACCTTTCGCCGGAGGCGA-3'
CHR 5'-TTTTACGCGTAGCGAGCGGCTGCAGATTTG-3'
BDF 5'-TTTTGGATCCGTTTGTAATAAGAGAATGACCGAA-3'
BDR 5'-TTTTGGATCCAGGTCTCCTTGGTAATTTGGGTAC-3'
BHF 5'-TTTTACGCGTGTTTGTAATAAGAGAATGACCGAA-3'
BHR 5'-TTTTACGCGTAGGTCTCCTTGGTAATTTGGGTAC-3'
RT-PCR & Northern Blot F1 5'-AGCTGTACATGGAGATCTTGC-3'
F2 5'-AAAATCAAGACCCTGCGCCTG-3'
F3 5'-GCGAAATGAGTCTGGTAGGTG-3'
F4 5'-CGACCCATGTAATATGTAACA-3'
F5 5'-AATGGGATTCTCTATTTGTGCTG-3'
F6 5'-GAAGGCACAGATCATTCATGG-3'
R1 5'-CTCACTGTGCTTTTCAAGATTTC-3'
R2 5'-CTTGTCGTTGCTGCTCACT-3'
R3 5'-CACAGTGGTTTATTGAATACTTAC-3'
R4 5'-CACCT ACCAGACTCA TTTCGC-3'
R5 5'-TCAGCTAGAAAACTGTATAAGAG-3'
R6 5'-ACCACAAGCAGTCTCATGGGA-3'
R7 5'-CAGTAAAAAAAACAGTTTGAAAGGC-3'
Forward primers are denoted F, reverse primers are denoted R; GSPH1-GSPD1 are gene specific primers for 3'- and 5'-RACE. BPF-BHR were used 
for amplification of fragments for subsequent cloning of reporter gene constructs A–F (restriction sites are underlined). F1–6 and R1–7 are primers 
used for RT-PCR and generation of Northern Blot probes.BMC Molecular Biology 2009, 10:28 http://www.biomedcentral.com/1471-2199/10/28
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ogy analysis was performed by comparing sequences of
different species with the human sequence of the bidirec-
tional promoter using the ALIGN-webtool, which calcu-
lates a global alignment between two sequences http://
www.ch.embnet.org/software/LALIGN_form.html. Pre-
diction of putative TFBS was performed using the program
Motif http://motif.genome.jp/.
Reporter gene constructs and luciferase assays
The intergenic region between HAND2  and  DEIN  was
amplified by PCR from human genomic DNA with the
primers BPF and BPR (table 1) containing a 10 bp cloning
adaptor with a HindIII-restriction site. It was then cloned
in both orientations into the HindIII-site of the pGL3-
Luciferase reporter Vector (constructs A and D, fig. 3;
Promega, Darmstadt, Germany).
The 302 bp long putative cis-regulatory element "C" was
amplified by PCR with the primers CDF and CDR and
cloned downstream of the luciferase gene into the BamHI-
site of the DEIN-promoter vector (construct B, fig. 3). For
cloning of construct E, "C" was amplified with the primers
CHF and CHR and cloned upstream of the luciferase gene
into the MluI-site of the HAND2-promoter vector (con-
struct E, fig. 3). The 90 bp long enhancer for HAND2-
expression in branchial arches (BAE) was PCR amplified
with the primers BDF and BDR and cloned downstream of
the luciferase gene into the BamHI-site of the DEIN-pro-
moter-vector (construct C, fig. 3). For cloning of construct
F, "BAE" was amplified with the primers BHF and BHR
and cloned upstream of the luciferase gene into the MluI-
site of the HAND2-promoter vector (construct F, fig. 3).
All constructs were sequenced with the BigDye Terminator
Kit (PE Applied Biosystems, Foster City, USA) to ensure
the correct orientation and nucleotide sequence. NB cell
lines SH-EP, SK-N-AS, SH-SY5Y and Kelly were cultured in
RPMI medium supplemented with 10% FCS. Cells were
transfected using Lipofectamin 2000 (Invitrogen, Karl-
sruhe, Germany) following the manufacturer's instruc-
tions. Approximately 3 × 104 cells were transferred into
96-well plates and transfected with a mixture containing 1
μg of the respective reporter construct and 2 ng of pRL-
CMV (Promega), which contains the Renilla luciferase
gene under the cytomegalovirus SV 40 promoter and
enhancer serving as an internal control. Cells were har-
vested and lysed 27–30 h after transfection and the luci-
ferase activity was detected using the Dual Luciferase
Reporter Assay Kit (Promega) and measured with a lumi-
nometer (Mitras, Berthold, Germany) according to the
manufacturer's instructions. The luciferase activity of the
reporter plasmids was normalized to the renilla luciferase
acitivity. Each transfection experiment was carried out
three times in duplicate and a total of four measurements
for each construct were performed. Student's t-test was
used to calculate the statistical significance between the
relative activities of the various constructs compared to
that of the promoterless vector.
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